Surging global incidence of ovarian cancer and gynecological malignancies among aging female populations, expanding clinical demand for reliable tumor markers in surgical staging and chemotherapy monitoring, and continuous in-vitro diagnostic (IVD) innovations in chemiluminescent immunoassays (CLIA) and automated clinical analyzers are driving rapid growth across the global CA-125 Test Market....